[HTML][HTML] Association of the epithelial–mesenchymal transition (EMT) with cisplatin resistance

M Ashrafizadeh, A Zarrabi, K Hushmandi… - International journal of …, 2020 - mdpi.com
Therapy resistance is a characteristic of cancer cells that significantly reduces the
effectiveness of drugs. Despite the popularity of cisplatin (CP) as a chemotherapeutic agent …

Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas

MK Jolly, JA Somarelli, M Sheth, A Biddle… - Pharmacology & …, 2019 - Elsevier
Cancer metastasis and therapy resistance are the major unsolved clinical challenges, and
account for nearly all cancer-related deaths. Both metastasis and therapy resistance are …

[HTML][HTML] The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance

N Loret, H Denys, P Tummers, G Berx - Cancers, 2019 - mdpi.com
Ovarian cancer is the most lethal of all gynecologic malignancies and the eighth leading
cause of cancer-related deaths among women worldwide. The main reasons for this poor …

[HTML][HTML] Targeted therapies in gynecological cancers: A comprehensive review of clinical evidence

Q Wang, H Peng, X Qi, M Wu, X Zhao - Signal Transduction and …, 2020 - nature.com
Advanced and recurrent gynecological cancers are associated with poor prognosis and lack
of effective treatment. The developments of the molecular mechanisms on cancer …

The emerging role of lncRNAs in the regulation of cancer stem cells

R Castro-Oropeza, J Melendez-Zajgla, V Maldonado… - Cellular Oncology, 2018 - Springer
Background Tumors contain a functional subpopulation of cells that exhibit stem cell
properties. These cells, named cancer stem cells (CSCs), play significant roles in the …

[HTML][HTML] Triptolide attenuates renal tubular epithelial-mesenchymal transition via the MiR-188-5p-mediated PI3K/AKT pathway in diabetic kidney disease

M Xue, Y Cheng, F Han, Y Chang, Y Yang… - … Journal of Biological …, 2018 - ncbi.nlm.nih.gov
Triptolide possesses the trait of renal protection. Epithelial-mesenchymal transition (EMT) is
closely linked to the pathogenesis of diabetic kidney disease (DKD). MicroRNAs have …

[HTML][HTML] Complex determinants of epithelial: mesenchymal phenotypic plasticity in ovarian cancer

Y Klymenko, O Kim, MS Stack - Cancers, 2017 - mdpi.com
Unlike most epithelial malignancies which metastasize hematogenously, metastasis of
epithelial ovarian cancer (EOC) occurs primarily via transcoelomic dissemination …

[HTML][HTML] Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or …

S Zhang, T Leng, Q Zhang, Q Zhao, X Nie… - Biomedicine & …, 2018 - Elsevier
Objective This study aimed to investigate the antitumor effects and possible regulatory
mechanisms of sanguinarine in epithelial ovarian cancer. Material and methods The effects …

[HTML][HTML] Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes

H Liu, L Tang, Y Li, W Xie, L Zhang, H Tang, T Xiao… - Molecular Cancer, 2024 - Springer
The incidence of nasopharyngeal carcinoma (NPC) exhibits significant variations across
different ethnic groups and geographical regions, with Southeast Asia and North Africa …

[HTML][HTML] Sphingosine kinase 1 promotes the metastasis of colorectal cancer by inducing the epithelial-mesenchymal transition mediated by the FAK/AKT/MMPs axis

SQ Liu, CY Xu, WH Wu, ZH Fu… - International …, 2018 - spandidos-publications.com
It was demonstrated that Sphingosine kinase 1 (SphK1) promotes tumor progression and
confers the malignancy phenotype of colorectal cancer by activating the focal adhesion …